|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06185 CANSINOBIO
Nominal 
33.040 -0.780 (-2.306%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2025 | EPS | 11.00 RMB (cts) | |
| Net Profit | 27.87 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2026 | 231.50 | 93.35 | 0 | -- | 337.00 | 126.00 |
| 2027 | 446.50 | 180.50 | 0 | -- | 558.00 | 335.00 |
| 2028 | 769.50 | 311.00 | 0 | -- | 932.00 | 607.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2026 | 337.00 | 136.00 | -- | UBS | Buy | 59.80 | 01/04/2026 | |
| 2026 | 126.00 | 50.70 | -- | BANK OF AMERICA | Buy | 47.90 | 01/04/2026 | |
| 2027 | 558.00 | 226.00 | -- | UBS | -- | -- | 01/04/2026 | |
| 2027 | 335.00 | 135.00 | -- | BANK OF AMERICA | -- | -- | 01/04/2026 | |
| 2028 | 932.00 | 377.00 | -- | UBS | -- | -- | 01/04/2026 | |
| 2028 | 607.00 | 245.00 | -- | BANK OF AMERICA | -- | -- | 01/04/2026 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 02/04/2026 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 27,873 |
| %Change | -- |
| EPS / (LPS) | RMB 0.110 |
| NBV Per Share (¥) | RMB -- |